{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:43:15Z","timestamp":1791204195578,"version":"4.2.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":586,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.5604\/01.3001.0010.5493","type":"journal-article","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T09:08:46Z","timestamp":1509181726000},"page":"S4-S14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":545,"special_numbering":"S1","title":["Bile Acid Physiology"],"prefix":"10.1016","volume":"16","author":[{"given":"Agostino","family":"Di Ciaula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Garruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Lunardi Baccetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonilde","family":"Bonfrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Q.-H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0010.5493_bib0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile Acid Signaling in Metabolic Disease and Drug Therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacological Reviews"},{"key":"10.5604\/01.3001.0010.5493_bib0010","series-title":"The Biliary System","author":"Wang","year":"2017"},{"key":"10.5604\/01.3001.0010.5493_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/gut.19.1.32","article-title":"Physiological factors influencing serum bile acid levels","volume":"19","author":"Ponz De Leon","year":"1978","journal-title":"Gut"},{"key":"10.5604\/01.3001.0010.5493_bib0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gut.19.11.1006","article-title":"Diurnal serum levels of primary conjugated bile acids. Assessment by specific ra-dioimmunoassays for conjugates of cholic and chenodeoxy-cholic acid","volume":"19","author":"Schalm","year":"1978","journal-title":"Gut"},{"key":"10.5604\/01.3001.0010.5493_bib0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM197410032911401","article-title":"Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption","volume":"291","author":"LaRusso","year":"1974","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0010.5493_bib0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J Lipid Res"},{"key":"10.5604\/01.3001.0010.5493_bib0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","article-title":"Bile acids are nutrient signaling hormones","volume":"86","author":"Zhou","year":"2014","journal-title":"Steroids"},{"key":"10.5604\/01.3001.0010.5493_bib0040","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/hep.22204","article-title":"Coordinate regulation of gallbladder motor function in the gut-liver axis","volume":"47","author":"Portincasa","year":"2008","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5493_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"10.5604\/01.3001.0010.5493_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","article-title":"Bile Acid sulfation: a pathway of bile acid elimination and detoxification","volume":"108","author":"Alnouti","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.5604\/01.3001.0010.5493_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jchromb.2013.10.019","article-title":"The profile of bile acids and their sulfate metabolites in human urine and serum","volume":"942-943","author":"Bathena","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.5604\/01.3001.0010.5493_bib0060","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/eci.12161","article-title":"New insights into the molecular mechanism of intestinal fatty acid absorption","volume":"43","author":"Wang","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.5604\/01.3001.0010.5493_bib0065","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.5604\/01.3001.0010.5493_bib0070","doi-asserted-by":"crossref","first-page":"83951","DOI":"10.18632\/oncotarget.13796","article-title":"Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"key":"10.5604\/01.3001.0010.5493_bib0075","article-title":"Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the Bacterial Burden in Two Mouse Models of Enteric Infection","volume":"85","author":"Tremblay","year":"2017","journal-title":"Infect Im-mun"},{"key":"10.5604\/01.3001.0010.5493_bib0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"10.5604\/01.3001.0010.5493_bib0085","first-page":"25","article-title":"Bile acids in regulation of inflammation and immunity: friend or foe?","volume":"34","author":"Zhu","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.5604\/01.3001.0010.5493_bib0090","doi-asserted-by":"crossref","first-page":"G81","DOI":"10.1152\/ajpgi.00065.2015","article-title":"Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling","volume":"310","author":"Dossa","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.5604\/01.3001.0010.5493_bib0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4161\/gmic.21216","article-title":"Is bile acid a determinant of the gut microbiota on a high-fat diet?","volume":"3","author":"Yokota","year":"2012","journal-title":"Gut Microbes"},{"key":"10.5604\/01.3001.0010.5493_bib0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/nu2050551","article-title":"When food meets man: the contribution of epigenet-ics to health","volume":"2","author":"De Fabiani","year":"2010","journal-title":"Nutrients"},{"key":"10.5604\/01.3001.0010.5493_bib0105","series-title":"Hepatology","article-title":"Transintestinal cholesterol excretion (TICE): A secondary, non-biliary pathway contributing to reverse cholesterol transport","author":"Wang","year":"2017"},{"key":"10.5604\/01.3001.0010.5493_bib0110","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1021\/bi00581a024","article-title":"Quasie-lastic light scattering studies of aqueous biliary lipid systems. Size, shape, and thermodynamics of bile salt micelles","volume":"18","author":"Mazer","year":"1979","journal-title":"Biochemistry"},{"key":"10.5604\/01.3001.0010.5493_bib0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0005-2760(86)90260-2","article-title":"Cholesterol-phospholipid vesicles in human bile: an ultrastructural study","volume":"879","author":"Somjen","year":"1986","journal-title":"Biochim.Biophys.Acta"},{"key":"10.5604\/01.3001.0010.5493_bib0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-2275(20)34326-1","article-title":"Contribution of vesicular and micellar carriers to cholesterol transport in human bile","volume":"26","author":"Somjen","year":"1985","journal-title":"J Lipid Res"},{"key":"10.5604\/01.3001.0010.5493_bib0125","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI109025","article-title":"The physical chemistry of cholesterol solubility in bile. Relation to gallstone formation and dissolution in man","volume":"61","author":"Carey","year":"1978","journal-title":"J Clin Invest"},{"key":"10.5604\/01.3001.0010.5493_bib0130","doi-asserted-by":"crossref","first-page":"155S","DOI":"10.1002\/hep.1840040828","article-title":"Metastability behavior of supersaturated bile","volume":"4","author":"Holzbach","year":"1984","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5493_bib0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/242336a0","article-title":"Liquid crystals in human bile","volume":"242","author":"Olszewski","year":"1973","journal-title":"Nature"},{"key":"10.5604\/01.3001.0010.5493_bib0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0005-2760(78)90033-4","article-title":"Liquid crystals and cholesterol nucleation during equilibration in supersaturated bile analogs","volume":"528","author":"Holzbach","year":"1978","journal-title":"Biochim.Biophys.Acta"},{"key":"10.5604\/01.3001.0010.5493_bib0145","first-page":"86","article-title":"Effects of changes of plasma motilin level on the motility of gallbladder in patients with chronic renal failure","volume":"35","author":"Wang","year":"1996","journal-title":"Chung.Hua.Nei.Ko.Tsa.Chih"},{"key":"10.5604\/01.3001.0010.5493_bib0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease","volume":"368","author":"Portincasa","year":"2006","journal-title":"Lancet"},{"key":"10.5604\/01.3001.0010.5493_bib0155","series-title":"Gallstones. Recent advances in epidemiology, pathogenesis, diagnosis and management","first-page":"1","year":"2017"},{"key":"10.5604\/01.3001.0010.5493_bib0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1586\/17474124.2016.1109445","article-title":"Management of gallstones and its related complications","volume":"10","author":"Portincasa","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5493_bib0165","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/00365521.2013.799220","article-title":"Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options","volume":"48","author":"Bonfrate","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5493_bib0170","series-title":"Gastroenterol Rep (Oxf)","article-title":"Irritable bowel syndrome and diet","author":"Portincasa","year":"2017"},{"key":"10.5604\/01.3001.0010.5493_bib0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.5604\/01.3001.0010.5493_bib0180","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/ijc.30643","article-title":"Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis","volume":"140","author":"Cao","year":"2017","journal-title":"Int J Cancer"},{"key":"10.5604\/01.3001.0010.5493_bib0185","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.5604\/01.3001.0010.5493_bib0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/01635581.2012.630164","article-title":"Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations","volume":"64","author":"Ou","year":"2012","journal-title":"Nutr Cancer"},{"key":"10.5604\/01.3001.0010.5493_bib0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/19490976.2016.1150414","article-title":"Taurocholic acid metabolism by gut microbes and colon cancer","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.5604\/01.3001.0010.5493_bib0200","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1038\/ncomms7342","article-title":"Fat, fibre and cancer risk in African Americans and rural Africans","volume":"6","author":"O\u2019Keefe","year":"2015","journal-title":"Nat Commun"},{"key":"10.5604\/01.3001.0010.5493_bib0205","doi-asserted-by":"crossref","first-page":"e59260","DOI":"10.1371\/journal.pone.0059260","article-title":"Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans","volume":"8","author":"Biedermann","year":"2013","journal-title":"PLoS One"},{"key":"10.5604\/01.3001.0010.5493_bib0210","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.5604\/01.3001.0010.5493_bib0215","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1021\/acs.chemrestox.6b00401","article-title":"Multi-Om-ics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites, and Metabolic Pathways","volume":"30","author":"Gao","year":"2017","journal-title":"Chem Res Toxicol"},{"key":"10.5604\/01.3001.0010.5493_bib0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1289\/EHP202","article-title":"Sex-Specific Effects of Organophosphate Diazinon on the Gut Microbiome and Its Metabolic Functions","volume":"125","author":"Gao","year":"2017","journal-title":"Environ Health Perspect"},{"key":"10.5604\/01.3001.0010.5493_bib0225","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1007\/s11356-012-1283-4","article-title":"Impact of chronic exposure to low doses of chlorpyrifos on the intestinal microbiota in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and in the rat","volume":"20","author":"Joly","year":"2013","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.5604\/01.3001.0010.5493_bib0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MPG.0000000000000734","article-title":"Chlorpyrifos Exposure During Perinatal Period Affects Intestinal Microbiota Associated With Delay of Maturation of Digestive Tract in Rats","volume":"61","author":"Joly Condette","year":"2015","journal-title":"J Pediatr Gastroenter-ol Nutr"},{"key":"10.5604\/01.3001.0010.5493_bib0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproduc-ibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"10.5604\/01.3001.0010.5493_bib0240","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00324.2015","article-title":"Protective effect of agaro-oli-gosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice","volume":"310","author":"Higashimura","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Phys-iol"},{"key":"10.5604\/01.3001.0010.5493_bib0245","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.5604\/01.3001.0010.5493_bib0250","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ijc.30219","article-title":"Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis","volume":"139","author":"Xie","year":"2016","journal-title":"Int J Cancer"},{"key":"10.5604\/01.3001.0010.5493_bib0255","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.5604\/01.3001.0010.5493_bib0260","series-title":"J Diabetes Invest","article-title":"Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes","author":"Liu","year":"2017"},{"key":"10.5604\/01.3001.0010.5493_bib0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap\u2014 bile acids in metabolic control","volume":"10","author":"Kuipers","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.5604\/01.3001.0010.5493_bib0270","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.5604\/01.3001.0010.5493_bib0275","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"key":"10.5604\/01.3001.0010.5493_bib0280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1534-5807(02)00187-9","article-title":"Redundant pathways for negative feedback regulation of bile acid production","volume":"2","author":"Wang","year":"2002","journal-title":"Dev Cell"},{"key":"10.5604\/01.3001.0010.5493_bib0285","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s11695-017-2549-1","article-title":"Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids","volume":"27","author":"Mazidi","year":"2017","journal-title":"Obes Surg"},{"key":"10.5604\/01.3001.0010.5493_bib0290","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fphar.2017.00162","article-title":"Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases","volume":"8","author":"Festa","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.5604\/01.3001.0010.5493_bib0295","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab"},{"key":"10.5604\/01.3001.0010.5493_bib0300","first-page":"5118","article-title":"Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1","volume":"8","author":"Liu","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.5604\/01.3001.0010.5493_bib0305","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.tiv.2012.12.020","article-title":"Bile acids in the colon, from healthy to cytotoxic molecules","volume":"27","author":"Barrasa","year":"2013","journal-title":"Toxicol In Vitro"},{"key":"10.5604\/01.3001.0010.5493_bib0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2013","journal-title":"Nature Reviews Gastroenter-ology & Hepatology"},{"key":"10.5604\/01.3001.0010.5493_bib0315","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/er.2000-0035","article-title":"Bile acid regulation of gene expression: roles of nuclear hormone receptors","volume":"23","author":"Chiang","year":"2002","journal-title":"Endocr Rev"},{"key":"10.5604\/01.3001.0010.5493_bib0320","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2741\/A273","article-title":"Regulation of bile acid synthesis","volume":"3","author":"Chiang","year":"1998","journal-title":"Front Biosci"},{"key":"10.5604\/01.3001.0010.5493_bib0325","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","article-title":"Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms","volume":"40","author":"Chiang","year":"2004","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0010.5493_bib0330","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/me.2011-0033","article-title":"Ligand-Dependent Regulation of the Activity of the Orphan Nuclear Receptor, Small Heterodimer Partner (SHP), in the Repression of Bile Acid Biosynthetic CYP7A1 and CYP8B1 Genes","volume":"25","author":"Miao","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.5604\/01.3001.0010.5493_bib0335","doi-asserted-by":"crossref","first-page":"27703","DOI":"10.1074\/jbc.M302128200","article-title":"Farnesoid X receptor regulates bile acid-amino acid conjugation","volume":"278","author":"Pircher","year":"2003","journal-title":"J Biol Chem"},{"key":"10.5604\/01.3001.0010.5493_bib0340","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-2275(20)32022-8","article-title":"Subcellular organization of bile acid amidation in human liver: a key issue in regulating the biosynthesis of bile salts","volume":"41","author":"Solaas","year":"2000","journal-title":"J Lipid Res"},{"key":"10.5604\/01.3001.0010.5493_bib0345","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1665-2681(19)31170-6","article-title":"The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease","volume":"14","author":"Aguilar-Olivos","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.5604\/01.3001.0010.5493_bib0350","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.5604\/01.3001.0010.5493_bib0355","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/mp700105z","article-title":"Mini-review: endocrine actions of fibroblast growth factor 19","volume":"5","author":"Jones","year":"2008","journal-title":"Mol Pharm"},{"key":"10.5604\/01.3001.0010.5493_bib0360","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"key":"10.5604\/01.3001.0010.5493_bib0365","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.5604\/01.3001.0010.5493_bib0370","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"10.5604\/01.3001.0010.5493_bib0375","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1074\/jbc.M010878200","article-title":"Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway","volume":"276","author":"Gupta","year":"2001","journal-title":"J Biol Chem"},{"key":"10.5604\/01.3001.0010.5493_bib0380","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.bcp.2005.08.020","article-title":"Inhibition of insulin\/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytes","volume":"70","author":"Dent","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.5604\/01.3001.0010.5493_bib0385","doi-asserted-by":"crossref","first-page":"304292","DOI":"10.1155\/2012\/304292","article-title":"A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways","volume":"2012","author":"Garruti","year":"2012","journal-title":"J Lipids"},{"key":"10.5604\/01.3001.0010.5493_bib0390","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1158\/0008-5472.CAN-08-1791","article-title":"Nuclear bile acid receptor FXR protects against intestinal tu-morigenesis","volume":"68","author":"Modica","year":"2008","journal-title":"Cancer Res"},{"key":"10.5604\/01.3001.0010.5493_bib0395","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2009.09.060","article-title":"The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors","volume":"138","author":"Modica","year":"2010","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0010.5493_bib0400","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.42.6.830","article-title":"Moti-lin induces gall bladder emptying and antral contractions in the fasted state in humans","volume":"42","author":"Luiking","year":"1998","journal-title":"Gut"},{"key":"10.5604\/01.3001.0010.5493_bib0405","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2982.2000.00217.x","article-title":"Acute intraduode-nal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans","volume":"12","author":"Portincasa","year":"2000","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"10.5604\/01.3001.0010.5493_bib0410","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/j.2040-4603.2016.tb00717.x","article-title":"Functions of the Gallbladder","volume":"6","author":"Housset","year":"2016","journal-title":"Compr Physiol"},{"key":"10.5604\/01.3001.0010.5493_bib0415","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling","volume":"12","author":"Choi","year":"2006","journal-title":"Nat Med"},{"key":"10.5604\/01.3001.0010.5493_bib0420","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.5604\/01.3001.0010.5493_bib0425","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"key":"10.5604\/01.3001.0010.5493_bib0430","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0006-291X(78)91196-8","article-title":"Effect of lymphatic drainage on 7alpha-hydroxylation of cholesterol in rat liver","volume":"85","author":"Bjorkhem","year":"1978","journal-title":"Biochem Biophys Res Commun"},{"key":"10.5604\/01.3001.0010.5493_bib0435","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbadis.2010.11.011","article-title":"Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications","volume":"1812","author":"Kemper","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.5604\/01.3001.0010.5493_bib0440","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol Cell"},{"key":"10.5604\/01.3001.0010.5493_bib0445","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1194\/jlr.M400102-JLR200","article-title":"Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor","volume":"45","author":"Nishimaki-Mogami","year":"2004","journal-title":"J Lipid Res"},{"key":"10.5604\/01.3001.0010.5493_bib0450","first-page":"4719","article-title":"Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio","volume":"14","author":"Modica","year":"2008","journal-title":"Frontiers in bioscience (Landmark edition)"},{"key":"10.5604\/01.3001.0010.5493_bib0455","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","article-title":"New molecular insights into the mechanisms of cholestasis","volume":"51","author":"Wagner","year":"2009","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0010.5493_bib0460","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.RES.0000143422.83209.be","article-title":"Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?","volume":"95","author":"Ory","year":"2004","journal-title":"Circ Res"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:36:44Z","timestamp":1761647804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119310385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":92,"alternative-id":["S1665268119310385"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0010.5493","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bile Acid Physiology","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0010.5493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}